Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03480724 · ClinicalTrials.gov registry record · NA
Assessing the Efficacy of Virtual Reality Analgesia (VRA) in Pediatric Patients for Pain Control
A NA study, sponsored by Montefiore Medical Center.
- Terminated
- Registry status
- NA
- Development phase
- 55
- Enrollment target
NCT03480724 is a NA study that was terminated before completion, run by Montefiore Medical Center. The registered enrollment target is 55 participants.
The verdict
NCT03480724, a NA study, was terminated before completion, sponsored by Montefiore Medical Center.
- TERMINATED
- Registry status
- NA
- Development phase
- 55 participants
- Enrollment target
Study Summary
To evaluate the efficacy of virtual reality analgesia (VRA) for pediatric patients undergoing Botulinum toxin injections (BTI) for spasticity management. Patients will be assigned to one of three groups; one group of subjects will randomly be assigned to VRA intervention using Google Cardboard Virtual reality head- mounted display powered by a iPod touch, a second group of subjects will receive VRA with Oculus Rift, and a third group of subjects will receive no intervention beyond standard sedation, anesthetic, and/or restraint-this group will serve as the control group.
Interventions
- OTHER Google Cardboard VRA
- OTHER Oculus Rift VRA
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 55 participants |
| Start Date | 2017-07-06 |
| Est. Completion | 2023-10-27 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03480724
The ClinicalTrials.gov registry entry for NCT03480724 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 55 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Montefiore Medical Center, which has 345 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Google Cardboard VRA is the first listed.
NCT03480724 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03480724 about?
NCT03480724 is a clinical study titled "Assessing the Efficacy of Virtual Reality Analgesia (VRA) in Pediatric Patients for Pain Control". To evaluate the efficacy of virtual reality analgesia (VRA) for pediatric patients undergoing Botulinum toxin injections (BTI) for spasticity management. Patients will be assigned to one of three groups; one group of subjects will randomly be assigned to VRA intervention using Google Cardboard Virtu...
What is the current status of trial NCT03480724?
This trial is currently terminated. It is a NA study. The enrollment target is 55 participants. The study started on 2017-07-06. Estimated completion is 2023-10-27.
What interventions are being tested in trial NCT03480724?
The interventions under investigation include: Google Cardboard VRA (OTHER), Oculus Rift VRA (OTHER).
Who is sponsoring clinical trial NCT03480724?
This trial is sponsored by Montefiore Medical Center, which has 345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.